Biopharmaceutical Performance Enhancement via Nano Sized Crystalline and Amorphous Solid Dispersed Materials

18 September 2023 09:10 - 09:40

  • Biopharmaceutical performance enhancement technologies
  • Nano-sized crystalline material
  • Amorphous Solid Dispersed Materials and SDD
  • Performance enhancement vs. physical stability
The potential of applying the advanced material technologies like nano and amorphous materials to pharmaceutical science and product development is fast emerging and evident.  This presentation will focus on some pharmaceutical development key issues including drug product performance and physical stability and how to use novel material technologies to mitigate the risks, illustrated by nano material and SDD product development case study examples.

Shawn Yin, Scientific Director, Bristol-Myers Squibb